You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
LDN (Low Dose Naltrexone) is a proven-safe (by the FDA in 50mg doses!) off-label prescription drug which has gained a great deal of attention over the past few months due to its remarkable disease modifying effects of controlling and reversing symptoms of Parkinson's Disease. Lexie is one person who has experienced a reversal of most of her Parkinsons Disease symptoms over the past 5 years. She was officially diagnosed with Parkinsons disease in 2008 (although her non-motor symptoms began 20 years earlier). In this question and answer format with Robert Rodgers, PhD from Parkinsons Recovery, Lexie offers detailed information about her experience with taking LDN. She has been able to titrate ...
"I had not encountered Dr. Thomas Cowan before reviewing this book--boy, have I been missing something ... This book is probably the best self-help guide for the healing arts that has ever been written" --Nancy Parsons, waldorfbooks.com "Readers will be pleased to know that its author, Dr. Thomas Cowan, combines the best of Eastern and Western esoteric wisdom in the healing arts with the best of modern findings in Western medicine.... This collaboration pulls together a mix of expertise that offers health seekers some truly holistic solutions." --Duncan M. Roads, editor, Nexus magazine What is the Fourfold Path to Healing? It is a unique, comprehensive view of medicine, a holistic approach t...
A repertoire of 10 TLRs mediate the first response to all microbes that infect mammals. They are the long sought receptors for a wide range of microbial products. Notable examples include TLR4 which recognizes LPS from gram negative bacteria, TLR3 which recognizes viral double-stranded RNA and TLR9 which recognizes CpG DNA motifs, found commonly in both viruses and bacteria. TLRs are increasingly being implicated in both infectious and inflammatory diseases, notable examples being sepsis, inflammatory bowel disease, atherosclerosis and asthma. There is therefore great interest in targeting TLRs therapeutically since blocking TLRs will result in a decrease in the production of inflammatory mediators such as TNF. This volume covers our current understanding of TLRs, and their role in inflammation. Given the primacy of TLRs in the inflammatory process and their emerging role in inflammatory diseases the book is of great interest to researchers working in inflammation and immunology.
A new approach to growing local medicine, including information on geo-authenticity, wildcrafting, and developing a good business plan "[A] beautiful and informative book . . . A dirt-smudged copy should be within easy reach of every home gardener or farmer who grows—or wants to grow—medicinal plants."—Michael McGuffin, President, American Herbal Products Association Both a business guide and a farming manual, The Organic Medicinal Herb Farmer will teach readers how to successfully grow and market organic medicinal Western herbs. Whether you’re trying to farm medicinal plants, culinary herbs, or at-risk native herbs exclusively or simply add herbal crops to what you’re already grow...
First published in Germany in 1929, The End and the Beginning is a lively personal memoir of a vanished world and of a rebellious, high-spirited young woman's struggle to achieve independence. Born in 1883 into a distinguished and wealthy aristocratic family of the old Austro-Hungarian Empire, Hermynia Zur Muhlen spent much of her childhood travelling in Europe and North Africa with her diplomat father. After five years on her German husband's estate in czarist Russia she broke with both her family and her husband and set out on a precarious career as a professional writer committed to socialism. Besides translating many leading contemporary authors, notably Upton Sinclair, into German, she ...
Naltrexone is an opiate antagonist drug developed in the 1970s and approved by the FDA in 1984 for opiate and drug abuse treatment. When used at much lower doses in an off-label protocol referred to as low dose naltrexone (LDN), the drug has been shown to halt disease progression in Crohn's disease and certain cancers, to reduce symptoms in multiple sclerosis and autism, and to improve numerous autoimmune and neurodegenerative conditions, including Parkinson's disease and amyotrophic lateral sclerosis (ALS). Grounded in clinical and scientific research, this book describes the history of naltrexone, its potential therapeutic uses, its effects on the immune system, its pharmacological properties, and how the drug is administered. It also lists fillers and compounding pharmacies, doctors who prescribe LDN, and patient resources, and includes interviews with LDN patients and researchers.
This book is about Low Dose Natlrexone, a low-cost treatment for autoimmune diseases such Crohn's, Fibromyalgia, Chronic Fatigue Syndrome, Rheumatoid Arthritis, MS, Lupus, etc. There are patient contributions from the US, UK and Europe
Mifepristone (RU486), the first clinically available antiprogestin, has generated great interest since its discovery in the early 1980s. Today, it is recognized that mifepristone, along with other antiprogestins, has a potentially significant therapeutic role in human health and disease, with likely applicability to a variety of pregnancy-related conditions (e.g., management of labor) and to contraception, endometriosis, and cancer, among others. But because mifepristone has been studied and used most widely as a means of nonsurgical abortion, political issues have thus far limited research on the drug and prevented its introduction into the U.S. market. This book provides an unbiased evaluation of current knowledge about both the fundamental nature of antiprogestins as well as their possible use in treating numerous diseases and conditions, and it contains recommendations for future research.
Schemes involving students as tutors are in place in many countries. This work aims to stimulate and encourage the use of an educational technique through which teachers in tertiary and secondary education can amplify and extend their influence - through the deployment of students as tutors.
A comprehensive examination of Low Dose Naltrexone—a little-known drug with big potential "[LDN] raises hopes of reversing memory loss in old age."—the Guardian A drug that is simultaneously affordable, devoid of severe side effects, and applicable to a wide range of diseases is not often found in the modern pharmaceutical landscape. But as medical professionals and researchers alike continue to discover, Low Dose Naltrexone (LDN) boasts this remarkable combination. LDN, originally prescribed in higher doses as a treatment for opioid addiction, works by blocking opioid receptors, thereby stimulating the production of endorphins, mitigating the inflammatory process, and stabilizing the im...